Looking to list your PhD opportunities? Log in here.
This project is no longer listed on FindAPhD.com and may not be available.
Click here to search FindAPhD.com for PhD studentship opportunitiesAbout the Project
· Background
Microbial Keratitis (MK) - an infection of the cornea caused by invading bacteria or fungi - is an ophthalmic emergency and a major cause of blindness. Poor patient outcomes from MK are multifactorial and relate to access to care, limitations in current diagnostic procedures and treatment options. These usually target only the invading microorganism with antimicrobials, without mitigation of excessive and uncontrolled inflammatory responses, which leads to scarring and corneal perforation.
Working with our collaborators at the Aravind Eye Care System, India (the world’s largest and most productive eye care system) we are seeking to better understand these fundamental inflammatory processes in order to develop new diagnostic and treatment strategies to ultimately improve patient outcomes.
· About the Project
The applicant will receive training in, and have the opportunity to perform fundamental biological research into host-pathogen interactions and the inflammatory responses to MK at the molecular level (including development of cell-culture systems, ex vivo porcine corneal infection models and working with patient tear and corneal tissue samples in omics based approaches). The insights gained will enable target selection for the development and evaluation of novel activity-based biosensors (chemistries which report on pathogen or host response – synthesised in-house), and the rational selection of immunomodulatory agents for incorporation into the model systems. There will be significant scope for research exchange to the Aravind Eye Care System to carry out fundamental research, diagnostic prototype evaluation, and to better understand the clinical and community requirements for alternative diagnostic and treatment options for MK. This knowledge will feed into our needs-driven, user-centric translational strategy.
The applicant will be placed within a dynamic, multidisciplinary team and will have the opportunity to collaborate with a wide group of researchers, including microbiologists, immunologists, chemists, engineers, healthcare technologists and clinicians both in the UK and India.
The research group is located in the University of Edinburgh Centre for Inflammation Research; a world-class research environment at the interface between biological and medical science, with multidisciplinary groupings focused on inflammation, infection, disease and repair. The Centre is based within the Edinburgh Medical School in the outstanding facilities of the Queen’s Medical Research Institute at the site of the Royal Infirmary of Edinburgh hospital, maximising future translational opportunities.
As part of the application process, please fill and submit the online application form.
Funding Notes
The studentship will be awarded competitively. Applicants should hold at least an upper second class degree or equivalent in a relevant discipline (eg immunology, microbiology, biochemistry, biology). Applicants should submit the following documents: (i) Personal statement about their research interests and their reasons for applying; and (ii) CV.
References
All documents should be submitted to CIR.Postgraduate@ed.ac.uk no later than 5pm on 21 February.
Short-listed candidates will be notified by email.
Informal enquiries can be sent via email to beth.mills@ed.ac.uk

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Edinburgh, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Novel strategies for the diagnosis and treatment of snakebites
University of Reading
Investigation of the critical roles of platelets at the interface between thrombosis and inflammation in order to develop improved therapeutic strategies for the treatment and/or prevention of cardiovascular/inflammatory diseases
University of Reading
Investigating novel therapeutic targets for the treatment of cancer stem cells in neuroblastoma
Kingston University